4559:TYO
Zeria Pharmaceutical Co Ltd
¥1,977.00
arrow_upward
+1.91%(+37.00) 1D
Oct 15, 10:26:11 AM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥1,950
High
¥1,976
Low
¥1,941
Mkt. cap
98.99B
Avg. vol.
159.02K
Volume
53.60K
Dividend
2.48%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.58
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
Open
¥1,950
High
¥1,976
Low
¥1,941
Mkt. cap
98.99B
Avg. vol.
159.02K
Volume
53.60K
Dividend
2.48%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.58
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
S&P 500, Nasdaq See Worst Day In Over Two Months As Chipmaker Rout Deepens, CPI Data Comes In Hot — AAPL, SPCX, DRAM, SOXX In Focus
MarketBeat
·
37 minutes ago
CoreWeave (NASDAQ:CRWV) CRO Jonathan Jones Sells 15,811 Shares of Stock
The Motley Fool
·
23 minutes ago
The S&P 500 Has Risen 30.6% in the First 20 Months of Trump's Second Term, Just Ahead of the 28.5% Gain Over the Same Stretch of His First Term. Here's Why That Comparison Matters for Investors Heading Into the Midterms.
Bloomberg.com
·
5 hours ago
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp